2023 annual financial data
ADMA Biologics 2023 Net margin
Direct answer
Net margin was -10.94%.
Operating income was 21,632,000 USD and net income was -28,239,000 USD.
Operating cash flow was 8,800,000 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 258,215,000 USD
- Operating income
- 21,632,000 USD
- Net income
- -28,239,000 USD
- Operating cash flow
- 8,800,000 USD